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http://dx.doi.org/10.1016/j.stemcr.2017.06.011SUMMARYAdventitial progenitor cells, including SCA-1+ and mesenchymal stem cells, are believed to be important in vascular remodeling. It has
been shown that SCA-1+ progenitor cells are involved in neointimal hyperplasia of vein grafts, but little is known concerning their
involvement in hyperlipidemia-induced atherosclerosis. We employed single-cell sequencing technology on primary adventitial mouse
SCA-1+ cells from wild-type and atherosclerotic-prone (ApoE-deficient) mice and found that a group of genes controlling cell migration
andmatrix protein degradationwas highly altered. Adventitial progenitors fromApoE-deficientmice displayed an augmentedmigratory
potential both in vitro and in vivo. This increased migratory ability was mimicked by lipid loading to SCA-1+ cells. Furthermore, we show
that lipid loading increased miRNA-29b expression and induced sirtuin-1 and matrix metalloproteinase-9 levels to promote cell
migration. These results provide direct evidence that blood cholesterol levels influence vascular progenitor cell function, which could
be a potential target cell for treatment of vascular disease.INTRODUCTION
Atherosclerosis is a condition whereby the arteries supply-
ing target organs, such as the brain and the heart, become
occluded. It is a disease of chronic inflammation and the
leading cause of heart ischemia (Lusis, 2000). It is character-
ized by subendothelial retention of modified lipoproteins,
causing local inflammation and neointimal lesion forma-
tion (Williams and Tabas, 1995). This local effect exacer-
bates the activation and consequent loss of the endothelial
cell (EC) layer and profound vascular smooth muscle cell
(vSMC) proliferation, as well as recruitment of monocytes
and activation of resident macrophages. Consequently,
all three layers that comprise the vascular cell wall (adven-
titia, media, and EC) undergo remodeling with an accumu-
lation of cellular and extracellular matrix (ECM) material.
Over the last decade, vascular progenitors have been iden-
tified in the vessel wall in humans and rodents (Alessandri
et al., 2001; Ferreira et al., 2007; Hill et al., 2010; Hu et al.,
2004; Invernici et al., 2008; Passman et al., 2008; Psaltis
et al., 2014; Sirker et al., 2009; Tang et al., 2012; Tavian
et al., 2005; Tilki et al., 2009; Wu et al., 2008; Xu et al.,
2003; Zengin et al., 2006). The murine adventitia contains
a heterogeneous population of progenitor/precursor cells
with the majority of them expressing stem cell antigen 1
(SCA-1). In atherosclerotic arteries, the adventitial layer
displays increased cell proliferation and inflammation
(for review see Seidelmann et al., 2014). Recent studies
have highlighted the potential role of the adventitia inStem Cell Re
This is an open access artithe development of neointimal lesion of vessel grafts
(Chen et al., 2013; Wong et al., 2013). However, less is
known about the involvement of vascular stem/progenitor
cells in native atherosclerosis, the leading cause of cardio-
vascular death in the general population.
Resident vascular progenitors possess a bilineage poten-
tial, able to differentiate into vSMCs and ECs, both
in vitro and in vivo (Hu et al., 2004; Torsney et al., 2005;
Wong et al., 2013). Utilization of an SM22-LacZ mouse
model showed that SCA-1+b-gal+ cells could be traced
to neointimal lesions, confirming their differentiation
toward an SMC-like phenotype. When adventitial SCA-1+
(AdvSCA-1+) cells were applied to the external side of
vein grafts, prior to isografting to ApoE knockout (KO)
and wild-type (WT) mice, they were shown to contribute
to lesions via unknown mechanisms.
These murine SCA-1+ cells have been identified as the
largest vascular progenitor cell population to date, with
subpopulations expressing C-KIT and CD34 (Hu et al.,
2004). Bone marrow-derived circulating cells may serve as
a second potential source of vascular progenitors. In sup-
port of this, SCA-1+ cells also express the macrophage/
monocyte marker CD45 (Psaltis et al., 2014). Noseda
et al. (2015) reported that there are at least two distinct
types of SCA-1+ cells in the adult mouse heart, with
one segregating to a cardiogenic potential and the other
toward a vascular one. Previously, we demonstrated that
SCA-1+-derived vSMCs present in neointimal lesions origi-
nated from non-bone marrow-derived resident vascularports j Vol. 9 j 681–696 j August 8, 2017 j Crown Copyright ª 2017 681
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
progenitors (Hu et al., 2002a, 2002b; Xu et al., 2003).
Although adventitial progenitors have been proposed to
contribute to vascular disease (Campagnolo et al., 2015;
Chen et al., 2013; Hu et al., 2004; Passman et al., 2008; Psal-
tis et al., 2014; Tigges et al., 2013), quantitative data on the
contribution of local resident versus bone marrow-derived
progenitors is still lacking.
For clarifying the role of AdvSCA-1+ progenitors in native
atherosclerosis, it is essential to elucidate their differential
gene expression profile between atherosclerosis-resistant
and atherosclerosis-susceptible mice. In identifying which
pathways are altered during naturally occurring atheroscle-
rosis, we may better understand their potential contribu-
tion to neointimal lesion development and maintenance.
Here, we employed single-cell gene expression analysis of
AdvSCA-1+ cells isolated from the adult aorta of WT and
ApoE KO mice. Our sequencing analysis revealed that
ApoE KO SCA-1+ cells have an altered gene expression pro-
file for cytoskeletal rearrangements compared with WT
SCA-1+ cells, making them more receptive to extrinsic
migratory cues. Subsequent mechanistic analysis with
a focus on ApoE KO SCA-1+ progenitors identified a poten-
tial cell-autonomous mechanism involving microRNA in
ameliorating adventitial progenitor migration that could
be of use in a clinical setting.RESULTS
A Gene Signature of a Heightened Migratory
Capability in ApoE KO AdvSCA-1+ Cells
WT mice do not develop atherosclerosis (Figure S1A). The
ApoE KOmice develop neointimal lesions and endothelial
layer lipid residues, along with an expanded adventitial
layer from 6 months onward (Figure S1B). The adventitia
and intima layers have been shown to contain SCA-1+ cells
(Hu et al., 2004). Immunolabeling of the descending aortas
and the root ofWT (Figure 1A) andApoEKOaortas revealed
an increase of SCA-1+ signal in both the adventitial and
intimal layers of the mutant vascular wall (Figure 1B), as
well as in vitro (Figure S2C). We confirmed this increase
by en face immunolabeling of both descending and
ascending aortas (Figures 1C–1E). To address the innate
heterogeneity of the AdvSCA-1+ cell population, we
collected unpassaged adventitial cells from both WT and
ApoE KOmice, obviating potential bias from in vitro expan-
sion. These cells were then enriched for SCA-1 surface
expression prior to single-cell expression analysis. A total
of 25,596 genes were analyzed between the two SCA-1+
cell populations (Figure 2A) and statistical analysis revealed
408 clustered genes thatwere significantly differentially ex-
pressed (Figure 2B). Gene Ontology (GO) pathway enrich-
ment analysis revealed four predominant pathways being682 Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017altered: cell migration, cytoskeletal organization, regula-
tion of locomotion, and endopeptidase activity (Figure 2C).
Enrichment for cellular components indicated several
pathways being affected, especially concerning ECM
organization and maintenance, including the exosome
pathway (Figure S1C).
Potential epithelialmigration, namely that of AdvSCA-1+
progenitor cell migration toward the inner vascular wall,
depends on the activity and gene expression of molecules
able to disrupt the ECM, as well as promoting cytoskeletal
rearrangements, including cell polarity. Our single-cell
expression analysis revealed thatmatrixmetallopeptidases,
integrins, and collagen gene expression differed between
ApoE KO and WT while AdvSCA-1+ cells in the mutant
setting suggested a heightened epithelial-to-mesen-
chymal transition (EMT) (Figure S1D). Of note, 5% of WT
AdvSCA-1+ cells expressed bone marrow hematopoietic
progenitor genes, compared with 20% of the ApoE KO
cells, fromwhich a subpopulation of 10%was also positive
for Cd45, 20% positive for Cd34, and 5% positive for Thy1
genes, as reported previously (Figure S1E; for review see
Bobryshev et al., 2015).
ApoE KO AdvSCA-1+ Enhanced Migration Is Intrinsic
To address any mechanisms that allow mutant AdvSCA-1+
cells to migrate more prominently, we first enriched our
single-cell expression analysis for those AdvSCA-1+ cells
with a high copy of Sca-1 (Figure 2D), since in our estab-
lished in vitro system setting passaged cells are used, which
are highly enriched for SCA-1 through multiple magnetic
bead cell sorting (Mayr et al., 2008; Yu et al., 2016). Our
findings were analyzed using genes known to correlate
with epithelial mouse cell expression (Seo et al., 2010;
Simpson et al., 2008) (Figure 2E). The ApoE KO’s epithelial
migration gene expression plexus was diverted in compar-
isonwithWT. To confirm this, we transducedWTandApoE
KO AdvSCA-1+ with an RFP lentiviral construct to perma-
nently label the cells and their progenies, if any. WT and
ApoE KO AdvSCA-1+-RFP cells were transplanted into the
outer wall of the femoral artery of adult WT and ApoE KO
mice in all four combinations (Figure 3A). Mice were then
euthanized 24 or 72 hr later. In comparison with the WT,
ApoE KO AdvSCA-1+ displayed a greater tendency to
migrate into the ApoE KO femoral artery. WT AdvSCA-1+
cells migrated poorly into the ApoE KO femoral artery
(Figure 3B).
We assessed whether specific genes are differentially
expressed between the ApoE-derived AdvSCA-1+ cells
compared with their WT counterparts (Figures S2A and
S2B). Thirteen genes identified were known to have an ef-
fect on migration; six of them were also important for EC
lumen formation, and five were important for leukocyte
homing. Of those, Cystatin c, Bone morphogenic protein 1
Figure 1. Adventitial ApoE KO SCA-1+ Cell Distribution Differs from That of WT
(A) Microphotograph of a 6-month-old mouse WT abdominal aorta and heart.
(B) Immunohistochemical labeling of WT and ApoE KO thoracic and root aortas for SCA-1 (green) and smooth muscle cell actin (SMa, red).
Inset: magnified photo of WT adventitia (n = 3 mouse aortas).
(C) En face immunohistochemical labeling of WT and ApoE KO ascending and descending EC layer for SCA-1 (green) and endothelial cell
marker (VE-cadherin) (n = 4 mouse aortas).
(D) Bar graph showing the number of SCA-1+ cells in both WT and ApoE KO EC layers of ascending and descending aortas (n = 14 inde-
pendent experiments). Student’s t test, p < 0.01.
(E) En face immunohistochemical labeling of the adventitia of the descending aorta of WT and ApoE KO 6-month-old mouse SCA-1 (green),
with notably more cells labeled in the ApoE KO adventitia (n = 3 mouse aortas).
Scale bars, 10 mm.(Bmp1), and Decorin (Dcn) were selected for further investi-
gation of AdvSCA-1+ cell migration. Since Bmp1 expression
was elevated, we assessed whether soluble Decorin (DCN)
and a BMP1-specific inhibitor (C15H24N4O4, iBMP1) would
be able to modulate cell migration in a wound-healing
assay (von Marschall and Fisher, 2010) (Figure S2D). DCN
was detected in the adventitia of WT aortas (Al Haj Zen
et al., 2006), confirming the single-cell data outcome (Fig-
ure S2E). In contrast, DCN expression was observed in
the medial layer of the ApoE KO in SMCs. This was
confirmed by ELISA on WT and ApoE KO AdvSCA-1+ as
well as in SMCs, in vitro, in concert with our single-cell
expression profiling. DCN and iBMP1 both decreased the
migration of ApoE KO AdvSCA-1+ cells when administeredindividually and in combination. We then tested the effect
of these substances in transwell migration assays (Fig-
ure 4A). Cystatin C had no effect on migration (data not
shown), while iBMP1 affected both mutant and WT
AdvSCA-1+ cells. DCN influenced ApoE KO AdvSCA-1+
cell migration toward SMCs. To confirm this, we used the
CRISPR/Cas9 genome-editing tool to knock out Dcn and
Bmp1 in WT and mutant cells and then assess their migra-
tion potential (Figures 4B, S3A, and S3B). Our data showed
that BMP1 absence significantly mitigated migration,
while absence of DCN enhanced it. We sought to investi-
gate whether DCN and inhibition of BMP1 could amelio-
rate the increased migration observed in ApoE KO
AdvSCA-1+ cells in vivo (Figure 4C). When ApoE KO cellsStem Cell Reports j Vol. 9 j 681–696 j August 8, 2017 683
(legend on next page)
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were treated with DCN and transplanted to the WT extra-
vascular cell wall of the femoral artery, they were mostly re-
tained in the adventitial andmedial layers. BMP1 inhibitor
treatment caused an even distribution of transplanted cells
throughout the vascular wall. These results demonstrate
that DCN and BMP1 levels influence AdvSCA-1+ cell
migration.
Based on these findings, we hypothesized that DCN and
BMP1 may induce a synergistic effect on their most prom-
inent target, collagen I (Ge and Greenspan, 2006; Keene
et al., 2000). To test this we set up 24-hr and 48-hr cell cul-
tures of semi-confluentWTand ApoE KO AdvSCA-1+, from
which supernatant was collected. Collagens I, II, and III
and BMP1 protein levels were measured via ELISA in the
presence of DCN and/or iBMP1 (Figures 4D and S3C). Pro-
tein levels in untreated cell cultures were in sync with gene
expression levels (Figure 4E). Collagen expression was
altered in the ApoE KO in comparison with WT. DCN
had no effect on collagen I protein in the ApoE KO, while
collagens II and III were affected in the WT, implying a
conditioned collagen assembly dysregulation in the
ApoE-deficient progenitors. Direct inhibition of BMP1
affected collagens I, II, and III of the WT progenitors
only. Administration of both reagents adjusted collagen
expression.
LDL-Bound and Free Cholesterol Are Potent Inducers
of AdvSCA-1+ Cell Migration, Inhibiting Their
Differentiation
In ApoE KO mice hyperlipidemia contributes to athero-
sclerosis, with ApoE KO AdvSCA-1+ cells displaying
enhanced cell migration. Cholesterol has been docu-
mented to be present in the adventitia (Yatera et al.,
2010). To interrogate the underlying mechanisms, we
loaded WT and ApoE KO AdvSCA-1+ with chol-MbD (wa-
ter-soluble cholesterol) to evaluate the effect on progenitor
cell migration. Transwell migration assays were performed,
demonstrating that ApoE KO AdvSCA-1+ progenitors dis-
played enhanced migration in response to chol-MbDFigure 2. Differential Gene Expression Profile between WT and A
(A) Scattergraph representing the relative single-cell expression of th
(n = 20, x axis) AdvSCA-1+ cells (type II error rate 0.2, r2 = 0.52).
(B) Heatmap representation of six major gene clusters showing the m
between WT and ApoE KO AdvSCA-1+ cells (Student’s t test, p < 0.01,
(C) GO biological processes revealed that key genes involved in regul
endopeptidase activity were downregulated 4-fold in the ApoE KO Adv
differentially expressed genes).
(D) Scattergraph representing the relative gene expression of AdvSCA-
between WT (n = 4, y axis) and ApoE KO (n = 5, x axis).
(E) Heatmap representation of median gene expression involved in N
from Simpson et al., 2008) shows a difference in relative expression
difference, Student’s t test, p < 0.01, with a bidirectional 2 SD cutofcompared with their WT counterparts (Figures 5A and
5B); DCN ameliorated this response, while iBMP1 admin-
istration showed contrasting results. Since ApoE KO
AdvSCA-1+ cell migration was influenced by cholesterol
and low-density lipoprotein (LDL) administration (Figures
S3D and S3E), we hypothesized that in vitro lipid loading
would increase cell migration in wound-healing assays.
Subsequent wound-healing assays also indicated a marked
increase in the migration of chol-MbD-loaded cells when
compared with untreated cells (Figure 5C). We confirmed
these observations by documenting the migration of sin-
gle AdvSCA-1+ progenitors using time-lapse microscopy
showing that chol-MbD-loaded progenitor cells possessed
increased migrational speed and persistence (Figures 5D
and 5E). Furthermore, immunofluorescence staining of
the chol-MbD-loaded progenitors revealed F-actin reorga-
nization, particularly nearer to the leading edge of the
cells, as indicated by the yellow arrowheads in Figure 5F.
Treatment with modified LDLs such as oxidized LDL
(Ox-LDL) and acetylated LDL (Ac-LDL) also induced
AdvSCA-1+ cell migration, to the same extent as chol-
MbD loading (Figure S3), confirming that the effects of
water-soluble cholesterol administration are similar to
those of natural cholesterol carriers. Additional data from
experiments performed using cell counting, bromodeox-
yuridine assays, and cyclin D1 expression profiling with
real-time RT-PCR indicated that chol-MbD, Ox-LDL, and
Ac-LDL inhibited progenitor cell proliferation (Figure S4).
Together, these data suggest that cholesterol can induce
SCA-1+ cell increased migration.
Since AdvSCA-1+ progenitors have a potential to differ-
entiate to other cells that make up the vascular wall, we
investigated whether chol-MbD or modified LDL loading
could induce this machinery. Interestingly, these mole-
cules did not induce differentiation into foam cells judged
by their gene expression profile (Figure S5). Furthermore,
the pre-treatment of progenitor cells with chol-MbD
seemed to have resulted in inhibition of SMC-related (Fig-
ure 5G) and EC-related (Figure 5H) gene expression.poE KO Adventitial SCA-1+ Progenitors
e 26,596 genes analyzed between WT (n = 18, y axis) and ApoE KO
edian statistically significant difference in relative gene expression
with a bidirectional 2 SD cutoff).
ation of cell migration, locomotion, cytoskeletal organization, and
SCA-1+ cell population, in comparison with the WT (Erim pruning, >5
1+ cells isolated, with high copy number of the Sca-1 gene, analyzed
IH3T3 murine fibroblast cell and epithelial cell migration (adapted
between WT and ApoE KO AdvSCA-1+ cells (>4-fold gene expression
f).
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Figure 3. ApoE KO SCA-1+ Cells Show a
Higher Migration toward the Inner
Vascular Wall in Comparison with WT
Counterparts
(A) Montage microphotographs. WT and
ApoE KO AdvSCA-1+ cells were transduced
with a nuclear RFP-inducing lentiviral
construct. 1 3 106 cells in Matrigel plugs
were transplanted to the outer side of the
vascular wall of femoral arteries, in WT and
ApoE KO 6-month-old animals. Cells were
allowed to migrate for 24 and 72 hr prior to
euthanizing the mice and assessing them
with en face immunolabeling, using a VE-
cadherin (green) antibody to mark the
endothelial cell layer. DAPI is blue.
(B) Quantitative and spatial analysis of
RFP+ cells migrating from the adventitia to
the lumen from the outer vascular wall after
24 and 72 hr. n = 3 transplantation exper-
iments, geometric means, error bars with
95% CI. *p < 0.05, **p < 0.01.Cholesterol Promotes Migration toward Pro-
inflammatory Cytokines
In parallel, we investigated the ability of AdvSCA-1+ pro-
genitors to migrate toward a panel of pro-inflammatory
cytokines, coinciding with altered gene expression of their
prospective surface receptors, in comparison with WT686 Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017AdvSCA-1+ cells (Figures S6A–S6C). Although interferon-g
and granulocyte macrophage colony-stimulating factor
showed a highmigration index, no differencewas observed
in combination with chol-MbD (data not shown). Instead,
SCA-1+ cells were able to augment theirmigration and loco-
motion in response to tumor necrosis factor a (TNF-a)
(legend on next page)
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combined with chol-MbD, as shown using transwell and
wound-healing assays (Figure 6A). These observations
were confirmed in single-cell tracking experiments using
time-lapse microscopy (Figures 6B and 6C). In a similar
fashion, pre-treatments with Ox-LDL and Ac-LDL were
also found to induce the migration of progenitor cells in
response to TNF-a (Figure S6D).
MiRNA-29bMediates Cholesterol-Induced SCA-1+ Cell
Migration
We aimed to elucidatemicroRNA expression that drives the
chol-MbD-mediated chemotactic induction of AdvSCA-1+
progenitors. We evaluated the potential changes of a panel
of miRNA following loading with chol-MbD (Figure S7A).
Chol-MbD markedly induced the expression of several
miRNAs includingmiRNAs 29b-3p and 32-5p, while several
miRNAs including 488-3p were inhibited. MicroRNAs 10a
and 10b are known to act in a compensatory manner (for
review see Feinberg and Moore, 2016). The induction of
miRNAs 29b-3p and 32-5p and inhibition of miRNA 488-
3p were subsequently confirmed using real-time PCR (Fig-
ures S7B–S7F).
MicroRNA 29b has been shown to participate in coronary
artery disease (Chen et al., 2011). To test whether miR-
29b is involved in the chol-MbD-mediated induction
of AdvSCA-1+ progenitor migration, we overexpressed
miRNA 29b in the AdvSCA-1+ progenitors by treating
them with an mmu-miR-29b-3p mirVana miRNA mimic
(Figure 6D). We observed that overexpression of miR-29
significantly increased SCA-1+ progenitor migration, both
stochastically and in the presence of TNF-a. Subsequent ex-
periments using an miRNA29 inhibitor showed a signifi-
cant reduction in miR-29 levels and attenuated the migra-
tion of chol-MbD-mediated cells (Figure 6E). It is thus
tempting to postulate that cholesterol can enhance
AdvSCA-1+ progenitors’ migratory response toward pro-in-
flammatory cytokines via miR-29b upregulation.Figure 4. Intervention Targets for Adventitial ApoE KO SCA-1+ In
(A) 13 105 WT or ApoE KO AdvSCA-1+ cells were loaded with 10 mg/mL
pass through 8.0-mm transwells seeded with 13 105 WT vSMCs for 24 h
95% CI. *p < 0.05. Scale bars, 50 mm.
(B) CRISPR/Cas9-edited AdvSCA-1+ cells were induced to migrate in 0
pendent experiments. Error bars are SEM. *p = 0.05 compared with co
(C) Montage microphotographs. WT and ApoE KO AdvSCA-1+ cells w
Matrigel plugs containing 13 106 cells were transplanted to the oute
(n = 3 transplantation experiments). Cells were allowed to migrate for
immunolabeling, using a VE-cadherin antibody to mark the EC layer. D
from the adventitia to the lumen from the outer vascular wall. *p < 0
(D) 33 104 WT or ApoE KO AdvSCA-1+ cells were seeded onto 12-well p
after 24 hr. ELISA assays were performed against pro-collagens I an
compared with untreated control. *p < 0.05, WT compared with ApoE
(E) Heatmap of Sca-1high cells differentially expressing Dcn, Bmp1, Co
688 Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017Cholesterol-InducedMigration IsMediated by Sirtuin-
1 Inhibition via MMP-9 Signaling
We next tested whether Sirtuin-1 (Sirt1) played a role in the
chol-MbD-mediated effects, since this molecule has been
involved in endothelial progenitor migration (Li et al.,
2015). Treatment of AdvSCA-1+ progenitor cells with
chol-MbD resulted in a suppression of Sirt1mRNA levels us-
ing RT-PCR (Figure 7A). Furthermore, the overexpression
and inhibition ofmiR-29were observed to cause an inhibi-
tion and induction of Sirt1 expression, respectively. Addi-
tionally the inhibition of SIRT1, using a specific inhibitor
(EX-527), markedly increased AdvSCA-1+ progenitor cell
migration, both randomly and toward TNF-a (Figure 7B).
Furthermore, treatmentwith chol-MbDormiR-29 caused
a marked increase in matrix metalloproteinase 9 (MMP-9)
expression in AdvSCA-1+ progenitor cells (Figures 7C and
7D). Consistently, the inhibition of miR-29 and SIRT-1 in
progenitor cells, in the presence of cholesterol, caused a
reduction and increase in Mmp-9 expression, respectively
(Figure 7E). We also observed that treatment with an
MMP-9 inhibitor regulated chol-MbD-mediatedmigration,
even in the presence of TNF-a (Figure 7F). Taken together,
these data suggest that chol-MbD can induce MiR-29,
which in turn suppresses Sirt1 and upregulates MMP-9
levels to induce AdvSCA-1+ progenitor cell migration.DISCUSSION
Previous studies have demonstrated that adventitial fibro-
blasts migrate from the adventitia to the neointima upon
balloon injury in rats (Li et al., 2000), while AdvSCA-1+ pro-
genitors potentially participate in neointimal aggravation
of vein grafts (Hu et al., 2004). Studies from our laboratory
have demonstrated their potential role in native athero-
sclerosis (Mayr et al., 2008). A recent report using lineage-
tracing analysis reported thatmore than 50%of neointimalhibition of Cell Migration toward the Media
iBMP1 and/or DCN in 0.2% fetal bovine serum (FBS) and allowed to
r. n = 3 independent experiments, geometric means, error bars with
.2% FBS passing through 8.0-mm transwells for 24 hr. n = 3 inde-
ntrol.
ere transduced with a nuclear RFP-inducing lentiviral construct.
r side of the vascular wall, in WT and ApoE KO 6-month-old animals
72 hr prior to euthanizing the mice and assessing them with en face
API is blue. Quantitative and spatial analysis of RFP+ cells migrating
.05 and **p < 0.01 compared with the untreated group.
lates and treated with iBMP1 and/or DCN. Supernatant was collected
d II, and collagen III. n = 3 independent experiments. *p < 0.05
KO.
l1a2, and Col3a1.
(legend on next page)
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SMCs derived from adventitial stem cells (Kramann
et al., 2016). We provide definitive evidence that athero-
sclerosis-prone-derived AdvSCA-1+ progenitors have a
different migration pattern to AdvSCA-1+ deriving from
atherosclerosis-protected mice. In the present study, we
show that hyperlipidemia triggers changes in gene expres-
sion in AdvSCA-1+ cells, promoting ECM remodeling and
cell migration. Collagen ratios are altered in ApoE KO
AdvSCA-1+ progenitors. Increase in collagen I/III ratio
due to fatty acid excess has been shown to cause cardiac
‘‘stiffness’’ (Beam et al., 2015). A metabolomics analysis re-
vealed a significant increase in fatty acid metabolites in
ApoE KO AdvSCA-1+ progenitors (our unpublished data).
The presence of pro-collagen II is an indication of the un-
avoidable discrepancies that appear between in situ and
in vitro experimental systems. It is also quite possible that
since SCA-1+ cells were allowed to migrate for 24 hr, in
the absence of leukemia inhibitory factor, they also began
producing collagen II due to differentiation.
There are several implications that derive from this study.
First, in situ single-cell gene sequencing indicates that the
majority of AdvSCA-1+ cells are local resident progenitor/
precursor cells, since a very small proportion of AdvSCA-1+
displayed bonemarrow cell markers. Second, water-soluble
cholesterol and modified LDLs are able to alter the gene
expression and function of AdvSCA-1+ cells related to
migration. Third, by combining single-cell differential
gene expression analysis with established in vitro and in vivo
cell migration systems, we reveal the use of potential mol-
ecules that can regulate AdvSCA-1+ migration.
We specifically link DCN and BMP1 to extracellular
collagen remodeling in cholesterol-loaded AdvSCA-1+
cells; in contrast, microRNA 29b induces migration,
possibly via Sirt1 (Schematic Diagram S1). DCN is a small
leucine-rich proteoglycan that plays important roles in
atherosclerosis (Singla et al., 2011). In Fischer et al.
(2000), reported an amelioration of intimal formation
upon balloon injury in rats after Dcn gene overexpression.
Although its expression is primarily observed in the tunicaFigure 5. Cholesterol Induces SCA-1+ Cell Migration and Inhibits
(A and B) 13 105 WT or ApoE KO AdvSCA-1+ cells were loaded with 20 m
free media and allowed to pass through 8.0-mm transwells in the pre
(C) Migration of SCA-1+ progenitor cells was evaluated using a wound
mean number of progenitors counted per 5 random fields of view at 2
(D) Vascular progenitor cells were seeded at 1 3 104 cells per well of
(E) Single-cell migration was documented using time-lapse microsco
(F) Changes in F-actin distribution was analyzed (yellow arrowheads
green) and DAPI (blue).
(G and H) The effect of cholesterol on smooth muscle cell (G) and end
light microscopy. Black arrows represent a change in cell morphology
expression using real-time RT-PCR. Graphs are shown as mean ± SEM
*p < 0.1, **p < 0.05, ***p < 0.01 compared with untreated control.
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(Fischer et al., 2001; Nili et al., 2003; Ueda et al., 2015). De-
corin overexpression reduces atherosclerosis in ApoE KO
mice (Al Haj Zen et al., 2006). Here, we show that in the
samemousemodel there is a shift of DCN expression/secre-
tion from the adventitia to themedial layer.Whether this is
a compensatorymechanism required for neointima stabili-
zation remains to be elucidated. Studies performed in the
skin of ApoE and DCN double KOs showed an overall
reduced DCN expression, similar to our findings in the
aorta (Hiebert et al., 2011). In diabetic nephropathy, DCN
acts in a protective manner, by reducing ECM accumula-
tion (Merline et al., 2009); its absence attracts more mono-
nuclear cells to the sites of insult, while in ocular fibroblasts
a combination of suramin and DCN specifically inhibits
collagen production (Mietz et al., 1997). A recent study in
abdominal aortic aneurysm showed that DCN stabilizes
the ECMand inflammation, preventing induced pathology
(Ueda et al., 2015). The authors cautiously note the dual
role of this molecule, promoting macrophage-induced pa-
thology while ameliorating a vSMC-induced one. It is
therefore highly likely that DCN’s role in atherosclerosis
is cell specific, as shown recently, in the human heart (Bar-
allobre-Barreiro et al., 2016).
DCN has been linked to collagen synthesis and BMP1
function (Keene et al., 2000; von Marschall and Fisher,
2010).We found that Bmp1 is overexpressed in themutant,
while collagen I and collagen III gene expression was altered.
The function of BMP1 on transforming growth factor b
(TGF-b) cleavage has been reported (Ge and Greenspan,
2006), while DCN also affects TGF-b’s function (Ferdous
et al., 2007). BMP1 is a potent pro-collagen cleavage prote-
ase that is involved in atherosclerosis (Derwall et al., 2012);
in fact, its reduction decreases vascular wall calcification.
We hypothesized that these molecules act synergistically
in collagen production in AdvSCA-1+ cells. The addition
of iBMP1 nearly abolished AdvSCA-1+ migration, with
minimal cell toxicity, while DCN addition affected only
ApoE KO SCA-1+ cells but not WT SCA-1+ cells. Thus,Differentiation
g/mL cholesterol along with 10 mg/mL iBMP1 and/or DCN in serum-
sence of 0.2% FBS for 24 hr.
-healing assay. Migration index for both assays was defined as the
03.
6-well plate and subjected to 48 hr of 20 mg/mL chol-MbD loading.
py, and quantified for speed and persistence.
) using immunofluorescence staining with phalloidin (Alexa 488;
othelial cell (H) differentiation was observed using phase-contrast
. Total RNA was harvested for analysis of smooth muscle cell gene
of three independent experiments (n = 3).
Scale bars, 20 mm.
Figure 6. Cholesterol Can Induce SCA-1+ Cell Migration toward Pro-inflammatory Cytokines, along with MicroRNA 29b
(A) Migration of vascular progenitor cells, either untreated or loaded with 20 mg/mL chol-MbD for 48 hr, toward 10 ng/mL TNF-a was
evaluated using transwell and wound-healing assays.
(B and C) SCA-1+ cells were seeded at 5 3 103 cells per well of 6-well plate and subjected to 48 hr of 20 mg/mL chol-MbD loading and
10 ng/mL TNF-a. Single-cell migration was documented using time-lapse microscopy and quantified for speed and persistence.
(legend continued on next page)
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Figure 7. MicroRNA 29b Affects Choles-
terol-Loaded SCA-1+ Cell Migration via
Sirtuin-1/MMP-9
(A) SCA-1+ cells were loaded with 20 mg/mL
chol-MbD, overexpressed with miRNA-29,
pre-treated with 50 mM EX-527 (SIRT-1 in-
hibitor), or treated with 20 mg/mL chol-
MbD and a hsa-miR-29b-3p ID: MH10103
mirVana miRNA inhibitor. A mirVana miRNA
inhibitor Negative Control #1 or DMSO were
used as controls where appropriate. Cell
lysates were harvested and subjected to
real-time PCR for the detection of Sirt-1
mRNA expression.
(B) Migration of SCA-1+ cell toward serum-
free media, with TNF-a (10 ng/mL) in the
presence of 50 mM EX-527 evaluated using
8.0-mm transwell assays.
(C and D) Cell lysates were collected and
western blotting was performed for MMP-9
detection.
(E) SCA-1+ cells were pre-loaded with chol-
MbD and treated with a hsa-miR-29b-3p ID:
MH10103mirVana miRNA inhibitor or 50 mM
EX-527. Cell lysates were harvested and
subjected to real-time RT-PCR.
(F) The effect of MMP-9 inhibition (pre-
treatment with 20 mM MMP-9 inhibitor II)
on the migration of chol-MbD loaded
cells toward serum-free media or TNF-a
(10 ng/mL) was evaluated using 8.0-mm
transwell assays.
Data in graphs are shown as mean ± SEM of
three independent experiments. *p < 0.1,
**p < 0.05, ***p < 0.01 compared with
untreated control.addition of DCN or DCN/iBMP1 fine-tunes ApoE KO
AdvSCA-1+ cells into a perhapsmoreWTAdvSCA-1+migra-
tory (atheroprotective) behavior.
The search for cues important for AdvSCA-1+ migration
led us to investigate a cohort of miRNAs in relation to
this. Lipid loading showed that ApoE KO progenitors
were indeed more prone to migrate toward SMCs, possibly
due to their altered ECM gene expression profile. Recently,
we reported that AdvSCA-1+ cells respond to vSMC-derived
chemokine cues contributing to neointima formation (Yu(D and E) Migration of SCA-1+ cell toward serum-free media, loaded wit
inhibitor. Scale bars, 100 mm.
(F and G) Migration of SCA-1+ cell toward serum-free media, or loaded
hsa-miR-29b-3p miRNA and its inhibitor.
Data in graphs are shown as mean ± SEM of three independent experi
control.
692 Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017et al., 2016). Since 1998, when the ApoE KO mouse model
was employed for studies of atherosclerosis and hyperlipid-
emia (Hofker et al., 1998), it has not been shown how LDLs
contribute to specific effects on AdvSCA-1+ cells. It has
been recently documented that DNA hypomethylation is
important for the onset of the disease, along with lifestyle
factors (Jiang et al., 2012). Thus, miRNA expression levels
may have a strong influence in controlling the disease.
Our experiments show that miR-29b elicits a response
to the migratory potential of lipid-loaded AdvSCA-1+,h 20 mg/mL chol-MbD and in the presence of hsa-miR-29b-3p miRNA
with 20 mg/mL chol-MbD and TNF-a (10 ng/mL) in the presence of
ments. *p < 0.1, **p < 0.05, ***p < 0.01 compared with untreated
possibly via Sirt1 and MMP-9, with the latter documented
to play a role in atherosclerosis (Chen et al., 2008; Gough
et al., 2006; Pleva et al., 2015), while the former is a mole-
cule now shown to be involved in AdvSCA-1+ progenitors.
Of note, it has been reported that humanMiR-29b has been
implicated in ECM remodeling including collagen regula-
tion (Kriegel et al., 2012), while its dysregulation inmurine
cardiac fibroblasts upon post-myocardial infraction led
to decreased collagen formation and fibrosis (van Rooij
et al., 2008). It was also interesting how pro-inflammatory
cytokines such as TNF-a affected this pathway, meaning
that innate immunity may play a crucial role.
Atherosclerosis is a chronic inflammatory disease charac-
terized by lipoprotein accumulation that carries cholesterol
inside the arteries. Accumulation of LDL and cholesterol
leads to aberrant activation of vSMCs and macrophages
within the vessel wall (Xu et al., 2015). Modified LDLs
havebeen also known to increase foamcell formation, influ-
encing lesion development (Cox et al., 2007). Although
these molecules have been implicated in pro- and anti-
atherosclerotic responses, their effect on Sca-1+ progenitors
has not been investigated. Loading of AdvSCA-1+ with
MbD had an immediate effect on their migration poten-
tial, causing cytoskeletal rearrangements characteristic of
increased locomotion. Ox- and Ac-LDL administration had
a modest effect on migration, along with affecting SCA-1+
cell proliferation and viability; in line with these results,
mRNA levels of known scavenger receptors that bindmodi-
fied LDL molecules such as Cd63, Cd68, Lox-1, Msra, and
others remained unchanged.We thus attempted to identify
the mechanism by which chol-MbD induces SCA-1+ ECM
modifications that induce migration. The role of MMP-9 in
this process has been documented in macrophage function
and arterial enlargement during atherosclerosis (Chen et al.,
2008;Goughet al., 2006;Karwowski et al., 1999; Tronc et al.,
2000). While this paper was being written, it was reported
that Mmp-9-deficient mice had an abnormal cholesterol
metabolism, leading to atherosclerosis (Hernandez-Anzaldo
et al., 2016). Here, we show that AdvSCA-1+ MMP-9 levels
were elevated significantly upon exposure to chol-MbD,
underscoring the potential ability of AdvSCA-1+ to alter
the ECM. Based on this, we investigated whether Sirt1
inhibition, whose expression has been reported to inhibit
atherosclerosis in vSMCs (Gorenne et al., 2013), also had
an effect on SCA-1+ progenitor migration. Indeed, by using
a specific inhibitor or loading with chol-MbD, progenitors’
migration indexwas increased in a linearly inverted fashion.
MicroRNA 29b-3p expression levels affected chol-MbD-
loaded AdvSCA-1+. Two of the mechanisms of action were
via a modest Sirt1 change and a massive MMP-9 upregula-
tion. To our knowledge, no report has shown to date that
an miRNA can alter the lipid-loaded migratory effect of
AdvSCA-1+ progenitors.In summary, our results provide some clarity of the
migratory mechanisms of resident AdvSCA-1+ progenitors.
(1) Hyperlipidemic mice possess more HSC-derived pro-
genitors in the adventitia, in concert with previous studies
(Hu et al., 2002a, 2002b); (2) AdvSCA-1+ cells from ApoE
KO mice are undergoing EMT, which could be an early
sign of vascular stiffening; (3) ApoE KO AdvSCA-1+ cells
have a higher migratory potential than their WT counter-
parts; finally, (4) it seems that the AdvSCA-1+ ApoE KO
cells show an altered ECM, possibly due to dysfunctional
lipid loading, which may trigger or augment an unwanted
para-inflammatory immune response, a characteristic of
age-related disease (Chen et al., 2012; Xu et al., 2009).
Therefore, these results could provide a potential strategy
for the treatment of atherosclerosis by directing adventitial
cell migration.EXPERIMENTAL PROCEDURES
Animals
All animal procedures were performed according to the protocol
reviewed by the Institution Ethics Committee and approved by
the UK Home Office. All mice used were on identical genetic
background.
Single-Cell Gene Expression Analysis
Mouse adventitial cells were collected and pooled from six aortas
of 6-month-oldmice, for each genotype. SCA-1+ cells were isolated
from primary cultured cells upon reaching 90% confluence using
a microbeads kit (Miltenyi Biotec, Bergisch Gladbach, Germany)
containing anti-SCA-1 immunomagnetic microbeads and a mag-
netic cell-sorting system column.Cells were further analyzed using
the Fluidigm C1 machine and workflow following the manufac-
turer’s protocol.
AdvSCA-1+ Progenitor Cell Culture and
Differentiation
Mouse adult progenitor cells were derived from an outgrowth
of adventitial tissues of vessel grafts as previously described (Hu
et al., 2004; Tsai et al., 2012).
Cell Transplantations
For the in vivo cell transplantations, 1 3 106 cells were immersed
inMatrigel for 30min on ice prior to transplanting them to the ex-
tra-adventitial space of the femoral artery of 6-month-old mice.
Decorin and iBMP1 were administered along with the Matrigel,
where appropriate. Mice were then euthanized 24 and 72 hr later,
and femoral arteries were collected and fixed on 4% paraformalde-
hyde for 15 min prior to further analysis.
Exogenous Proteins, Antagonists, Cholesterol, and
Modified LDL Loading
For a detailed description, see Supplemental Experimental
Procedures.Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017 693
Transwell Chemotaxis and Scratch-Wound Assays
For a detailed description, see Supplemental Experimental
Procedures.
MicroRNA Transient Transfection
Manipulation of miRNA levels in vascular progenitor cells
(cultured to 60%–70% confluence) was carried out using an
mmu-miR-29b-3pmousemirVana miRNAmimic (5 mM), according
to the manufacturer’s protocol.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, and one schematic diagram and can be
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2017.06.011.
AUTHOR CONTRIBUTIONS
I.K. designed and performed experiments, analyzed data, and
wrote the majority of the paper; M.M.W. designed and performed
experiments, analyzed data, and wrote part of the paper; C.M.F.P.
performed experiments; Y.X. performed transplantations; B.Y.
and Y.H. provided tissues; D.T.W. assisted with cell tracking;
W.N.N. helped in metabolomics and cell surface analysis; A.l.B.
provided reagents; Z.N. helped with experiments; C.Z., X.R., L.Z.,
and E.K. provided help with the study design; Q.X. conceived
themajor part of the study; L.Z. andQ.X. designed thewhole study
and obtained funding.
ACKNOWLEDGMENTS
This work was supported by the British Heart Foundation (RG/14/
6/31144 and RM/13/2/30158) and the National Natural Science
Foundation of China (91639302, 91339102, and 91539103).
Received: January 27, 2017
Revised: June 23, 2017
Accepted: June 23, 2017
Published: July 27, 2017REFERENCES
Al Haj Zen, A., Caligiuri, G., Sainz, J., Lemitre, M., Demerens, C.,
and Lafont, A. (2006). Decorin overexpression reduces atheroscle-
rosis development in apolipoprotein E-deficient mice. Atheroscle-
rosis 187, 31–39.
Alessandri, G., Girelli, M., Taccagni, G., Colombo, A., Nicosia, R.,
Caruso, A., Baronio, M., Pagano, S., Cova, L., and Parati, E. (2001).
Human vasculogenesis ex vivo: embryonal aorta as a tool for isola-
tion of endothelial cell progenitors. Lab. Invest. 81, 875–885.
Barallobre-Barreiro, J., Gupta, S.K., Zoccarato, A., Kitazume-
Taneike, R., Fava, M., Yin, X., Werner, T., Hirt, M.N., Zampetaki,
A., Viviano, A., et al. (2016). Glycoproteomics reveals decorin
peptides with anti-myostatin activity in human atrial fibrillation.
Circulation 134, 817–832.
Beam, J., Botta, A., Ye, J., Soliman, H., Matier, B.J., Forrest, M., Ma-
cLeod, K.M., and Ghosh, S. (2015). Excess linoleic acid increases694 Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017collagen I/III ratio and ‘‘stiffens’’ the heart muscle following high
fat diets. J. Biol. Chem. 290, 23371–23384.
Bobryshev, Y.V., Orekhov, A.N., and Chistiakov, D.A. (2015).
Vascular stem/progenitor cells: current status of the problem.
Cell Tissue Res. 362, 1–7.
Campagnolo, P., Tsai, T.N., Hong, X., Kirton, J.P., So, P.W., Margar-
iti, A., Di Bernardini, E., Wong, M.M., Hu, Y., Stevens, M.M., et al.
(2015). c-Kit+ progenitors generate vascular cells for tissue-
engineered grafts through modulation of the Wnt/Klf4 pathway.
Biomaterials 60, 53–61.
Chen, K.C.,Wang, Y.S., Hu, C.Y., Chang,W.C., Liao, Y.C., Dai, C.Y.,
and Juo, S.H. (2011). OxLDL up-regulates microRNA-29b, leading
to epigenetic modifications of MMP-2/MMP-9 genes: a novel
mechanism for cardiovascular diseases. FASEB J. 25, 1718–1728.
Chen, M., Zhao, J., Luo, C., Pandi, S.P., Penalva, R.G., Fitzgerald,
D.C., and Xu, H. (2012). Para-inflammation-mediated retinal
recruitment of bone marrow-derived myeloid cells following
whole-body irradiation is CCL2 dependent. Glia 60, 833–842.
Chen, Y., Aratani, Y., Osawa, T., Fukuyama, N., Tsuji, C., and
Nakazawa, H. (2008). Activation of inducible nitric oxide synthase
increases MMP-2 andMMP-9 levels in ApoE-knockout mice. Tokai
J. Exp. Clin. Med. 33, 28–34.
Chen, Y., Wong, M.M., Campagnolo, P., Simpson, R., Winkler, B.,
Margariti, A., Hu, Y., and Xu, Q. (2013). Adventitial stem cells in
vein grafts display multilineage potential that contributes to neo-
intimal formation. Arterioscler Thromb.Vasc. Biol. 33, 1844–1851.
Cox, B.E., Griffin, E.E., Ullery, J.C., and Jerome, W.G. (2007).
Effects of cellular cholesterol loading on macrophage foam cell
lysosome acidification. J. Lipid Res. 48, 1012–1021.
Derwall, M., Malhotra, R., Lai, C.S., Beppu, Y., Aikawa, E., Seehra,
J.S., Zapol, W.M., Bloch, K.D., and Yu, P.B. (2012). Inhibition
of bone morphogenetic protein signaling reduces vascular calcifi-
cation and atherosclerosis. Arterioscler Thromb. Vasc. Biol. 32,
613–622.
Feinberg, M.W., and Moore, K.J. (2016). MicroRNA regulation of
atherosclerosis. Circ. Res. 118, 703–720.
Ferdous, Z., Wei, V.M., Iozzo, R., Hook, M., and Grande-Allen, K.J.
(2007). Decorin-transforming growth factor-interaction regulates
matrix organization and mechanical characteristics of three-
dimensional collagen matrices. J. Biol. Chem. 282, 35887–35898.
Ferreira, L.S., Gerecht, S., Shieh, H.F., Watson, N., Rupnick, M.A.,
Dallabrida, S.M., Vunjak-Novakovic, G., and Langer, R. (2007).
Vascular progenitor cells isolated from human embryonic stem
cells give rise to endothelial and smooth muscle like cells and
form vascular networks in vivo. Circ. Res. 101, 286–294.
Fischer, J.W., Kinsella, M.G., Clowes, M.M., Lara, S., Clowes, A.W.,
andWight, T.N. (2000). Local expression of bovine decorin by cell-
mediated gene transfer reduces neointimal formation after balloon
injury in rats. Circ. Res. 86, 676–683.
Fischer, J.W., Kinsella, M.G., Levkau, B., Clowes, A.W., andWight,
T.N. (2001). Retroviral overexpression of decorin differentially af-
fects the response of arterial smoothmuscle cells to growth factors.
Arterioscler Thromb. Vasc. Biol. 21, 777–784.
Ge, G., and Greenspan, D.S. (2006). BMP1 controls TGFbeta1 acti-
vation via cleavage of latent TGFbeta-binding protein. J. Cell Biol.
175, 111–120.
Gorenne, I., Kumar, S., Gray, K., Figg, N., Yu, H., Mercer, J., and
Bennett, M. (2013). Vascular smooth muscle cell sirtuin 1 protects
against DNA damage and inhibits atherosclerosis. Circulation 127,
386–396.
Gough, P.J., Gomez, I.G., Wille, P.T., and Raines, E.W. (2006).
Macrophage expression of active MMP-9 induces acute plaque
disruption in apoE-deficient mice. J. Clin. Invest. 116, 59–69.
Hernandez-Anzaldo, S., Brglez, V., Hemmeryckx, B., Leung, D.,
Filep, J.G., Vance, J.E., Vance, D.E., Kassiri, Z., Lijnen, R.H., Lam-
beau, G., et al. (2016). Novel role for matrix metalloproteinase 9
in modulation of cholesterol metabolism. J. Am. Heart Assoc. 5,
e004228.
Hiebert, P.R., Boivin, W.A., Abraham, T., Pazooki, S., Zhao, H., and
Granville, D.J. (2011). Granzyme B contributes to extracellularma-
trix remodeling and skin aging in apolipoprotein E knockoutmice.
Exp. Gerontol. 46, 489–499.
Hill, K.L., Obrtlikova, P., Alvarez, D.F., King, J.A., Keirstead, S.A.,
Allred, J.R., and Kaufman, D.S. (2010). Human embryonic stem
cell-derived vascular progenitor cells capable of endothelial and
smooth muscle cell function. Exp. Hematol. 38, 246–257.e1.
Hofker, M.H., van Vlijmen, B.J., and Havekes, L.M. (1998). Trans-
genic mouse models to study the role of APOE in hyperlipidemia
and atherosclerosis. Atherosclerosis 137, 1–11.
Hu, Y., Davison, F., Ludewig, B., Erdel, M., Mayr, M., Url, M., Die-
trich, H., and Xu, Q. (2002a). Smooth muscle cells in transplant
atherosclerotic lesions are originated from recipients, but not
bone marrow progenitor cells. Circulation 106, 1834–1839.
Hu, Y., Mayr, M., Metzler, B., Erdel, M., Davison, F., and Xu, Q.
(2002b). Both donor and recipient origins of smooth muscle cells
in vein graft atherosclerotic lesions. Circ. Res. 91, e13–20.
Hu, Y., Zhang, Z., Torsney, E., Afzal, A.R., Davison, F., Metzler, B.,
and Xu, Q. (2004). Abundant progenitor cells in the adventitia
contribute to atherosclerosis of vein grafts in ApoE-deficient
mice. J. Clin. Invest. 113, 1258–1265.
Invernici, G., Madeddu, P., Emanueli, C., Parati, E.A., and Alessan-
dri, G. (2008). Human fetal aorta-derived vascular progenitor cells:
identification and potential application in ischemic diseases. Cyto-
technology 58, 43–47.
Jiang, Y., Zhang, H., Sun, T., Wang, J., Sun, W., Gong, H., Yang, B.,
Shi, Y., and Wei, J. (2012). The comprehensive effects of hyperlip-
idemia and hyperhomocysteinemia on pathogenesis of atheroscle-
rosis and DNA hypomethylation in ApoE-/- mice. Acta Biochim.
Biophys. Sin (Shanghai) 44, 866–875.
Karwowski, J.K., Markezich, A., Whitson, J., Abbruzzese, T.A., Zar-
ins, C.K., and Dalman, R.L. (1999). Dose-dependent limitation of
arterial enlargement by the matrix metalloproteinase inhibitor
RS-113,456. J. Surg. Res. 87, 122–129.
Keene, D.R., San Antonio, J.D., Mayne, R., McQuillan, D.J., Sarris,
G., Santoro, S.A., and Iozzo, R.V. (2000). Decorin binds near the C
terminus of type I collagen. J. Biol. Chem. 275, 21801–21804.
Kramann, R., Goettsch, C., Wongboonsin, J., Iwata, H., Schneider,
R.K., Kuppe, C., Kaesler, N., Chang-Panesso, M., Machado, F.G.,Gratwohl, S., et al. (2016). Adventitial MSC-like cells are progeni-
tors of vascular smoothmuscle cells and drive vascular calcification
in chronic kidney disease. Cell Stem Cell 19, 628–642.
Kriegel, A.J., Liu, Y., Fang, Y., Ding, X., and Liang, M. (2012). The
miR-29 family: genomics, cell biology, and relevance to renal and
cardiovascular injury. Physiol. Genomics 44, 237–244.
Li, G., Chen, S.J., Oparil, S., Chen, Y.F., and Thompson, J.A. (2000).
Direct in vivo evidence demonstrating neointimal migration of
adventitial fibroblasts after balloon injury of rat carotid arteries.
Circulation 101, 1362–1365.
Li, W., Du, D., Wang, H., Liu, Y., Lai, X., Jiang, F., Chen, D., Zhang,
Y., Zong, J., and Li, Y. (2015). Silent information regulator 1 (SIRT1)
promotes the migration and proliferation of endothelial progeni-
tor cells through the PI3K/Akt/eNOS signaling pathway. Int. J.
Clin. Exp. Pathol. 8, 2274–2287.
Lusis, A.J. (2000). Atherosclerosis. Nature 407, 233–241.
Mayr, M., Zampetaki, A., Sidibe, A., Mayr, U., Yin, X., De Souza,
A.I., Chung, Y.L., Madhu, B., Quax, P.H., Hu, Y., et al. (2008). Pro-
teomic and metabolomic analysis of smooth muscle cells derived
from the arterial media and adventitial progenitors of apolipopro-
tein E-deficient mice. Circ. Res. 102, 1046–1056.
Merline, R., Lazaroski, S., Babelova, A., Tsalastra-Greul, W.,
Pfeilschifter, J., Schluter, K.D., Gunther, A., Iozzo, R.V., Schaefer,
R.M., and Schaefer, L. (2009). Decorin deficiency in diabetic
mice: aggravation of nephropathy due to overexpression of profi-
brotic factors, enhanced apoptosis and mononuclear cell infiltra-
tion. J. Physiol. Pharmacol. 60 (Suppl 4), 5–13.
Mietz, H., Chevez-Barrios, P., Lieberman, M.W., Wendt, M., Gross,
R., and Basinger, S.F. (1997). Decorin and suramin inhibit ocular
fibroblast collagen production. Graefes Arch. Clin. Exp. Ophthal-
mol. 235, 399–403.
Nili, N., Cheema, A.N., Giordano, F.J., Barolet, A.W., Babaei, S.,
Hickey, R., Eskandarian, M.R., Smeets, M., Butany, J., Pasterkamp,
G., et al. (2003). Decorin inhibition of PDGF-stimulated vascular
smooth muscle cell function: potential mechanism for inhibition
of intimal hyperplasia after balloon angioplasty. Am. J. Pathol.163,
869–878.
Noseda,M., Harada,M.,McSweeney, S., Leja, T., Belian, E., Stuckey,
D.J., Abreu Paiva, M.S., Habib, J., Macaulay, I., de Smith, A.J., et al.
(2015). PDGFRalpha demarcates the cardiogenic clonogenic Sca1+
stem/progenitor cell in adult murinemyocardium. Nat. Commun.
6, 6930.
Passman, J.N., Dong, X.R., Wu, S.P., Maguire, C.T., Hogan, K.A.,
Bautch, V.L., and Majesky, M.W. (2008). A sonic hedgehog
signaling domain in the arterial adventitia supports resident
Sca1+ smooth muscle progenitor cells. Proc. Natl. Acad. Sci. USA
105, 9349–9354.
Pleva, L., Kusnierova, P., Plevova, P., Zapletalova, J., Karpisek, M.,
Faldynova, L., Kovarova, P., and Kukla, P. (2015). Increased levels
of MMP-3, MMP-9 and MPO represent predictors of in-stent
restenosis, while increased levels of ADMA, LCAT, ApoE and
ApoD predict bare metal stent patency. Biomed. Pap. Med. Fac.
Univ. Palacky Olomouc Czech Repub 159, 586–594.
Psaltis, P.J., Puranik, A.S., Spoon, D.B., Chue, C.D., Hoffman, S.J.,
Witt, T.A., Delacroix, S., Kleppe, L.S., Mueske, C.S., Pan, S., et al.Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017 695
(2014). Characterization of a resident population of adventitial
macrophage progenitor cells in postnatal vasculature. Circ. Res.
115, 364–375.
Seidelmann, S.B., Lighthouse, J.K., and Greif, D.M. (2014). Devel-
opment and pathologies of the arterial wall. Cell Mol. Life Sci.
71, 1977–1999.
Seo, M., Lee, W.H., and Suk, K. (2010). Identification of novel cell
migration-promoting genes by a functional genetic screen. FASEB
J. 24, 464–478.
Simpson, K.J., Selfors, L.M., Bui, J., Reynolds, A., Leake, D., Khvor-
ova, A., and Brugge, J.S. (2008). Identification of genes that regu-
late epithelial cell migration using an siRNA screening approach.
Nat. Cell Biol 10, 1027–1038.
Singla, S., Hu, C., Mizeracki, A., and Mehta, J.L. (2011). Decorin in
atherosclerosis. Ther. Adv. Cardiovasc. Dis. 5, 305–314.
Sirker, A.A., Astroulakis, Z.M., and Hill, J.M. (2009). Vascular pro-
genitor cells and translational research: the role of endothelial
and smoothmuscle progenitor cells in endogenous arterial remod-
elling in the adult. Clin. Sci. (Lond.) 116, 283–299.
Tang, Z., Wang, A., Yuan, F., Yan, Z., Liu, B., Chu, J.S., Helms, J.A.,
and Li, S. (2012). Differentiation of multipotent vascular stem cells
contributes to vascular diseases. Nat. Commun. 3, 875.
Tavian, M., Zheng, B., Oberlin, E., Crisan, M., Sun, B., Huard, J.,
and Peault, B. (2005). The vascular wall as a source of stem cells.
Ann. N. Y. Acad. Sci. 1044, 41–50.
Tigges, U., Komatsu, M., and Stallcup, W.B. (2013). Adventitial
pericyte progenitor/mesenchymal stem cells participate in the rest-
enotic response to arterial injury. J. Vasc. Res. 50, 134–144.
Tilki, D., Hohn, H.P., Ergun, B., Rafii, S., and Ergun, S. (2009).
Emerging biology of vascular wall progenitor cells in health and
disease. Trends Mol. Med. 15, 501–509.
Torsney, E., Hu, Y., and Xu, Q. (2005). Adventitial progenitor cells
contribute to arteriosclerosis. Trends Cardiovasc. Med. 15, 64–68.
Tronc, F., Mallat, Z., Lehoux, S., Wassef, M., Esposito, B., and
Tedgui, A. (2000). Role of matrix metalloproteinases in blood
flow-induced arterial enlargement: interaction with NO. Arterios-
cler Thromb. Vasc. Biol. 20, E120–E126.
Tsai, T.N., Kirton, J.P., Campagnolo, P., Zhang, L., Xiao, Q., Zhang,
Z., Wang, W., Hu, Y., and Xu, Q. (2012). Contribution of stem cells
to neointimal formation of decellularized vessel grafts in a novel
mouse model. Am. J. Pathol. 181, 362–373.
Ueda, K., Yoshimura, K., Yamashita, O., Harada, T., Morikage, N.,
and Hamano, K. (2015). Possible dual role of decorin in abdominal
aortic aneurysm. PLoS One 10, e0120689.696 Stem Cell Reports j Vol. 9 j 681–696 j August 8, 2017van Rooij, E., Sutherland, L.B., Thatcher, J.E., DiMaio, J.M.,
Naseem, R.H., Marshall, W.S., Hill, J.A., and Olson, E.N. (2008).
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 105,
13027–13032.
von Marschall, Z., and Fisher, L.W. (2010). Decorin is processed
by three isoforms of bone morphogenetic protein-1 (BMP1). Bio-
chem. Biophys. Res. Commun. 391, 1374–1378.
Williams, K.J., and Tabas, I. (1995). The response-to-retention
hypothesis of early atherogenesis. Arterioscler Thromb. Vasc.
Biol. 15, 551–561.
Wong, M.M., Winkler, B., Karamariti, E., Wang, X., Yu, B., Simp-
son, R., Chen, T., Margariti, A., and Xu, Q. (2013). Sirolimus stim-
ulates vascular stem/progenitor cell migration and differentiation
into smooth muscle cells via epidermal growth factor receptor/
extracellular signal-regulated kinase/beta-catenin signaling
pathway. Arterioscler Thromb. Vasc. Biol. 33, 2397–2406.
Wu, S.M., Chien, K.R., andMummery, C. (2008). Origins and fates
of cardiovascular progenitor cells. Cell 132, 537–543.
Xu, Q., Zhang, Z., Davison, F., and Hu, Y. (2003). Circulating pro-
genitor cells regenerate endothelium of vein graft atherosclerosis,
which is diminished in ApoE-deficient mice. Circ. Res. 93, e76–86.
Xu, H., Chen, M., and Forrester, J.V. (2009). Para-inflammation in
the aging retina. Prog. Retin. Eye Res. 28, 348–368.
Xu, X., Zhang, A., Li, N., Li, P.L., and Zhang, F. (2015). Concentra-
tion-dependent diversification effects of free cholesterol loading
on macrophage viability and polarization. Cell Physiol. Biochem.
37, 419–431.
Yatera, Y., Shibata, K., Furuno, Y., Sabanai, K.,Morisada, N., Nakata,
S., Morishita, T., Toyohira, Y., Wang, K.Y., Tanimoto, A., et al.
(2010). Severe dyslipidaemia, atherosclerosis, and sudden cardiac
death in mice lacking all NO synthases fed a high-fat diet. Cardio-
vasc. Res. 87, 675–682.
Yu, B., Wong, M.M., Potter, C.M., Simpson, R.M., Karamariti, E.,
Zhang, Z., Zeng, L., Warren, D., Hu, Y., Wang, W., et al. (2016).
Vascular stem/progenitor cell migration induced by smooth mus-
cle cell-derived chemokine (C-C motif) ligand 2 and chemokine
(C-X-C motif) ligand 1 contributes to neointima formation. Stem
Cells 34, 2368–2380.
Zengin, E., Chalajour, F., Gehling, U.M., Ito, W.D., Treede, H.,
Lauke, H., Weil, J., Reichenspurner, H., Kilic, N., and Ergun, S.
(2006). Vascular wall resident progenitor cells: a source for post-
natal vasculogenesis. Development 133, 1543–1551.
